✦ LIBER ✦

Pharmacokinetics, Preliminary Efficacy and Safety of Subcutaneous Melagatran and Oral Ximelagatran

✍ Scribed by Dr David Bergqvist, Jan-Helge Solhaug, Lena Holmdahl, Ulf G. Eriksson, Magnus Andersson, Barbro Boberg, Mats Ögren

Book ID: 119929903
Publisher: Springer International Publishing AG
Year: 2004
Tongue: English
Weight: 132 KB
Volume: 24
Category: Article
ISSN: 1179-1918
DOI: 10.2165/00044011-200424030-00001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence of Severe Renal Impairment on

Influence of Severe Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Ximelagatran and Subcutaneous Melagatran

✍ Dr Ulf G. Eriksson, Susanne Johansson, Per-Ola Attman, Henrik Mulec, Lars Frison 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 159 KB

Pharmacokinetics of Melagatran and the E

Pharmacokinetics of Melagatran and the Effect on Ex Vivo Coagulation Time in Orthopaedic Surgery Patients Receiving Subcutaneous Melagatran and Oral Ximelagatran

✍ Dr Ulf G. Eriksson, Jaap W. Mandema, Mats O. Karlsson, Lars Frison, Per Olsson G 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 209 KB

The pharmacodynamics and pharmacokinetic

The pharmacodynamics and pharmacokinetics of the oral direct thrombin inhibitor ximelagatran and its active metabolite melagatran: a mini-review

✍ David Gustafsson; Margareta Elg 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Comparable Pharmacokinetics and Pharmaco

Comparable Pharmacokinetics and Pharmacodynamics of Melagatran in Japanese and Caucasian Volunteers after Oral Administration of the Direct Thrombin Inhibitor Ximelagatran

✍ Dr Linda C. Wernevik, Per Nyström, Magnus Andersson, Gillis Johnsson, Anders Byl 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 213 KB

No Influence of Obesity on the Pharmacok

No Influence of Obesity on the Pharmacokinetics and Pharmacodynamics of Melagatran, the Active Form of the Oral Direct Thrombin Inhibitor Ximelagatran

✍ Dr Troy C. Sarich, Renli Teng, Gary R. Peters, Maria Wollbratt, Robert Homolka, 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 124 KB

Ximelagatran and melagatran vs. low-mole

Ximelagatran and melagatran vs. low-molecular-weight heparin in major orthopedic surgery: relationship between efficacy and safety and timing of initial administration

✍ P. ZUFFEREY; S. LAPORTE; S. MOLLIEX; C. AUBOYER; P. MISMETTI 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB